Clin2
NCT07662785Possibly a fitNot yet recruiting

Simvastatin cream for eyelid fatty deposits

Xanthelasma Palpebrarum

Part of Hormones & metabolism clinical trials.

This study tests a cream with simvastatin (a cholesterol medicine) to see if it can shrink yellowish fatty bumps called xanthelasma that appear around the eyelids. If you have these bumps and haven't had recent treatments, this might be an option to try a non-surgical approach.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older.
  • You have yellowish, fatty bumps around your eyes (xanthelasma) that a doctor has confirmed.
  • You have at least one bump that can be easily measured.
  • You haven't had surgery, laser, freezing, or other procedures to remove these bumps in the last 3 months.
  • You can avoid using other treatments on the bumps during the study, and you haven't used medicated eyelid creams in the last 4 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06869291Enrolling by invitation
Minimally invasive treatment for eyelid cholesterol deposits

This trial tests a new minimally invasive procedure using tiny tunnels and a heparin injection to treat xanthelasma (cholesterol deposits under the skin of the eyelids). It may help reduce the appearance of these deposits with less scarring than traditional methods.

Fuzhou, Fujian
NCT03131726Recruiting· Phase 3
Simvastatin for Graves eye disease in mild-to-moderate cases

This trial tests whether simvastatin (a cholesterol medicine) can improve eye symptoms from Graves’ eye disease. It is aimed at people with active mild-to-moderate disease and will also check safety with blood tests, heart/skin tolerance, and stomach health.

Malmö
NCT06399783Not yet recruiting· Phase 4
Simvastatin cream vs. steroid cream for patchy hair loss

This trial compares two creams—one with simvastatin (a cholesterol medicine) and one with a steroid—to see which works better for patchy hair loss caused by alopecia areata. It may help you if you have mild to moderate patchy hair loss and haven't used other treatments recently.

Asyut
NCT04971577Recruiting· Phase 2/Phase 3
Simvastatin for alcohol-related liver scarring in stable adults

This trial studies whether simvastatin (a cholesterol medicine) can improve or slow scarring of the liver caused by long-term alcohol use. Participants must have confirmed liver fibrosis on biopsy and be in a stable (compensated) phase of liver disease.

Barcelona
NCT07561450Not yet recruiting· Phase 4
Demodex Blepharitis Treatment in Scleral Lens Wearers

This study tests a new eye drop treatment for Demodex blepharitis (a mite-related eyelid condition) in people who wear special scleral contact lenses. If you have this condition and wear these lenses, this trial may help reduce your symptoms like redness, itching, and burning.

NCT06516419Recruiting
Stem cell cream for melasma study

This study tests a cream made from stem cell secretions to see if it can help reduce melasma (dark patches on the face). It may be an option for women who haven't improved with other treatments.

Jakarta Pusat, DKI Jakarta

Hear when a new Xanthelasma Palpebrarum trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.